Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Oden

Showing results (71-80 of 83) with videos related to

Pageof 9
Sort By:
The Pediatric Infectious Disease Journal|September 13, 2007
Methicillin-resistant Staphylococcus aureus outbreak in an intensive care nursery: potential for interinstitutional spreadJay R McDonald, Charlene M Carriker, Brian C Pien, et al.
Bone|November 16, 2004
A family history of fracture and fracture risk: a meta-analysisJ A Kanis, H Johansson, A Oden, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|January 15, 2005
Effects of three months of low molecular weight heparin (dalteparin) treatment after bypass surgery for lower limb ischemia--a randomised placebo-controlled double blind multicentre trialL Jivegård, C Drott, J Gelin, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 4, 2004
Smoking and fracture risk: a meta-analysisJ A Kanis, O Johnell, A Oden, et al.
British Journal of Cancer|April 16, 2009
TP53 mutations predict disease control in metastatic colorectal cancer treated with cetuximab-based chemotherapyA Oden-Gangloff, F Di Fiore, F Bibeau, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|July 12, 2002
A new approach to the development of assessment guidelines for osteoporosisJ A Kanis, D Black, C Cooper, et al.
Bone|July 23, 2004
A meta-analysis of previous fracture and subsequent fracture riskJ A Kanis, O Johnell, C De Laet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 3, 2018
Bevacizumab+chemotherapy versus chemotherapy alone in elderly patients with untreated metastatic colorectal cancer: a randomized phase II trial-PRODIGE 20 study resultsT Aparicio, O Bouché, J Taieb, et al.
European Journal of Cancer (Oxford, England : 1990)|May 20, 2018
Geriatric analysis from PRODIGE 20 randomized phase II trial evaluating bevacizumab + chemotherapy versus chemotherapy alone in older patients with untreated metastatic colorectal cancerT Aparicio, O Bouché, E Francois, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2017
Bevacizumab+chemotherapy versus chemotherapy alone in elderly patients with untreated metastatic colorectal cancer: a randomized phase II trial-PRODIGE 20 study resultsT Aparicio, O Bouché, J Taieb, et al.
Pageof 9

Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
The Pediatric Infectious Disease Journal|September 13, 2007
Methicillin-resistant Staphylococcus aureus outbreak in an intensive care nursery: potential for interinstitutional spreadJay R McDonald, Charlene M Carriker, Brian C Pien, et al.
Bone|November 16, 2004
A family history of fracture and fracture risk: a meta-analysisJ A Kanis, H Johansson, A Oden, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|January 15, 2005
Effects of three months of low molecular weight heparin (dalteparin) treatment after bypass surgery for lower limb ischemia--a randomised placebo-controlled double blind multicentre trialL Jivegård, C Drott, J Gelin, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 4, 2004
Smoking and fracture risk: a meta-analysisJ A Kanis, O Johnell, A Oden, et al.
British Journal of Cancer|April 16, 2009
TP53 mutations predict disease control in metastatic colorectal cancer treated with cetuximab-based chemotherapyA Oden-Gangloff, F Di Fiore, F Bibeau, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|July 12, 2002
A new approach to the development of assessment guidelines for osteoporosisJ A Kanis, D Black, C Cooper, et al.
Bone|July 23, 2004
A meta-analysis of previous fracture and subsequent fracture riskJ A Kanis, O Johnell, C De Laet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 3, 2018
Bevacizumab+chemotherapy versus chemotherapy alone in elderly patients with untreated metastatic colorectal cancer: a randomized phase II trial-PRODIGE 20 study resultsT Aparicio, O Bouché, J Taieb, et al.
European Journal of Cancer (Oxford, England : 1990)|May 20, 2018
Geriatric analysis from PRODIGE 20 randomized phase II trial evaluating bevacizumab + chemotherapy versus chemotherapy alone in older patients with untreated metastatic colorectal cancerT Aparicio, O Bouché, E Francois, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2017
Bevacizumab+chemotherapy versus chemotherapy alone in elderly patients with untreated metastatic colorectal cancer: a randomized phase II trial-PRODIGE 20 study resultsT Aparicio, O Bouché, J Taieb, et al.
Pageof 9